pefloxacin has been researched along with Cross Infection in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arr, M; Ludwig, E; Székely, E | 1 |
| Bachmann, P; Gordiani, B; Ranchere, JY | 1 |
| Hostacká, A; Majtán, V | 1 |
| Bechrakis, P; Bilalis, D; Giamarellou, H; Mandragos, K; Pigas, K; Sfikakis, P | 1 |
| Potgieter, PD | 1 |
| Garvez, MD; Limson, BM; Peña, AC | 1 |
| Billard, M; Brun, Y; Etienne, J; Fleurette, J | 1 |
| Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 2 |
| Attisso, M; Bertrand, A; Beziau, H; Jonquet, O; Kassis, J; Perez, C; Pochet, I; Simeon De Buochberg, M | 1 |
| Berardi-Grassias, LD; Roy, O | 1 |
| Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL | 1 |
| Duerden, BI; Geary, I; Jones, BM; Lee, ME | 1 |
| Gille, Y; Marcatello, A; Robert, D; Tigaud, S; Vincent, P | 1 |
| Lochmann, O; Vyhnánek, F | 1 |
1 review(s) available for pefloxacin and Cross Infection
| Article | Year |
|---|---|
Clinical observations with Péflacine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Treatment Outcome | 1993 |
5 trial(s) available for pefloxacin and Cross Infection
| Article | Year |
|---|---|
Clinical observations with Péflacine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Treatment Outcome | 1993 |
Pefloxacin versus imipenem in the therapy of nosocomial lung infections of intensive care unit patients.
Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Cross Infection; Female; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Lung Diseases; Male; Middle Aged; Pefloxacin; Prospective Studies; Pseudomonas Infections; Time Factors | 1990 |
Monotherapy with pefloxacin in multidrug-resistant nosocomial gram-negative bacteraemia.
Topics: Administration, Oral; Adult; Aged; Cross Infection; Drug Resistance, Microbial; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pefloxacin; Pneumonia; Pseudomonas Infections; Sepsis | 1990 |
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
10 other study(ies) available for pefloxacin and Cross Infection
| Article | Year |
|---|---|
Postoperative infections in immunocompromised patients after oncological surgery.
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cross Infection; Female; Humans; Immunocompromised Host; Infection Control; Lung Neoplasms; Male; Middle Aged; Pefloxacin; Pneumonectomy; Prospective Studies; Risk Factors | 1995 |
Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Depression, Chemical; Dose-Response Relationship, Drug; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence | 1996 |
Pefloxacin therapy for nosocomial infections in the intensive care unit.
Topics: Cross Infection; Haemophilus Infections; Haemophilus influenzae; Half-Life; Humans; Intensive Care Units; Pefloxacin; Pneumococcal Infections; Streptococcus pneumoniae | 1990 |
Hospital dispersion of Staphylococcus epidermidis isolates resistant to a fluoroquinolone, pefloxacin.
Topics: Carrier State; Cross Infection; Drug Resistance, Microbial; Hand; Humans; Pefloxacin; Staphylococcal Infections; Staphylococcus epidermidis | 1989 |
[In vitro bactericidal effect of a piperacillin-pefloxacin combination against isolated strains of nosocomial pneumopathies in intensive care].
Topics: Cross Infection; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pefloxacin; Piperacillin | 1989 |
[Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Topics: Acinetobacter; Anti-Bacterial Agents; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nicotinic Acids; Norfloxacin; Pefloxacin; Pipemidic Acid; Pseudomonas aeruginosa; Staphylococcus | 1987 |
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia; Prospective Studies; Respiration, Artificial | 1988 |
Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Cross Infection; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Urinary Tract Infections | 1986 |
Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
Topics: Bacteria, Aerobic; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1985 |
[Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery].
Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Postoperative Complications; Premedication; Quinolones; Wounds and Injuries | 1995 |